Leaflet: information for the user
Ibuprofen Almus 600 mg film-coated tablets EFG
Read this leaflet carefully before you start taking this medicine.
-Keep this leaflet as you may need to read it again.
-If you have any questions, ask your doctor or pharmacist.
-This medicine has been prescribed for you. Do not pass it on to others even if their symptoms are the same. It may harm them.
-If you think you have suffered a side effect you can report it directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard.
1.What is Ibuprofen Almus and what it is used for
2.What you need to know before taking Ibuprofen Almus
3.How to take Ibuprofen Almus
4.Possible side effects
5.Storage of Ibuprofen Almus
6.Contents of the pack and other information
Ibuprofeno Almus belongs to a group of medicines called non-steroidal anti-inflammatory drugs (NSAIDs).
This medicine is indicated for the treatment of:
- fever,
- the treatment of moderate pain, including migraine, the treatment of rheumatoid arthritis (inflammation of the joints, including those of the hands and feet, leading to swelling and pain), juvenile rheumatoid arthritis, osteoarthritis (a chronic disorder that causes cartilage damage), ankylosing spondylitis (inflammation affecting the joints of the spine), non-rheumatic inflammation, and primary dysmenorrhea (painful menstruation).
Warnings and precautions
Consult your doctor or pharmacist before starting to take Ibuprofeno Almus:
This risk is higher when using high doses and prolonged treatment, in patients with a history of peptic ulcer disease, and in the elderly. In these cases, your doctor may consider associating a stomach protector medication.
It is essential to use the smallest dose that relieves or controls pain and not to take this medication for longer than necessary to control your symptoms.
Signs of allergic reaction to ibuprofen, such as respiratory problems, facial and neck swelling (angioedema), and chest pain, have been reported. Stop using Ibuprofeno Almus immediately and contact your doctor or emergency medical services if you observe any of these signs.
Be especially careful with Ibuprofeno Almus
Precautions in elderly patients
Elderly patients have a higher frequency of adverse reactions to NSAIDs, especially gastrointestinal bleeding and perforation, which can be fatal.
Severe skin reactions
Severe skin reactions, such as exfoliative dermatitis, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, drug reaction with eosinophilia and systemic symptoms (DRESS), generalized acute pustular exanthema (PEGA), have been reported in association with ibuprofen treatment. Discontinue Ibuprofeno Almus treatment and seek medical attention immediately if you notice any of the symptoms related to these severe skin reactions described in section 4.
Cardiovascular precautions
NSAIDs, such as ibuprofen, may be associated with a small increase in the risk of heart attack or stroke, especially when used in high doses. Do not exceed the recommended dose or treatment duration.
You should inform your doctor or pharmacist before taking Ibuprofeno Almus if:
These types of medications may also cause fluid retention, especially in patients with heart failure and/or high blood pressure.
Respiratory problems
Ibuprofen should be used with caution in patients who have or have had asthma, bronchial asthma, or other respiratory allergies, as it may cause bronchospasm, urticaria, or angioedema in these patients.
Precautions during pregnancy and in fertile women
Due to the association of NSAID administration with an increased risk of congenital anomalies/abortions, it is not recommended to administer Ibuprofeno Almus during the first and second trimesters of pregnancy, except in cases where it is strictly necessary. In these cases, the dose and duration should be limited to the minimum possible. It is believed that the risk increases with the dose and duration of treatment.
In the third trimester, the administration of Ibuprofeno Almus is contraindicated.
For fertile women, it should be noted that NSAIDs, such as Ibuprofeno Almus, have been associated with a decrease in the ability to conceive.
Infections
Ibuprofeno Almus may mask the signs of an infection, such as fever and pain. Therefore, it is possible that Ibuprofeno Almus may delay or prolong the treatment of the infection, increasing the risk of complications. This has been observed in pneumonia caused by bacteria and skin infections related to chickenpox. If you take this medication while having an infection and the symptoms of the infection persist or worsen, consult a doctor without delay.
Other medications and Ibuprofeno Almus
Inform your doctor or pharmacist if you are using or have recently used any other medication, including those purchased without a prescription.
Ibuprofeno Almus may affect or be affected by other medications. For example:
Other medications may also affect or be affected by Ibuprofeno Almus treatment. Therefore, always consult your doctor or pharmacist before using Ibuprofeno Almus with other medications.
The use of ibuprofen may alter the following laboratory tests:
Inform your doctor if you are to undergo a clinical analysis and are taking or have recently taken ibuprofen.
Taking Ibuprofeno Almus with food and drinks
It is recommended to take the medication with milk or with food, or immediately after eating, to reduce the possibility of stomach discomfort. Do not take alcohol, as it may increase gastrointestinal adverse reactions.
Pregnancy, breastfeeding, and fertility
Consult your doctor or pharmacist before using any medication.
The use of this medication is not recommended in women trying to become pregnant. It should not be takenduring pregnancy, especially in the last 3 months(see section on precautions during pregnancy and in fertile women),as it may harm the fetus or cause problems during delivery. It may cause kidney and heart problems in your fetus. It may affect your predisposition and that of your baby to bleeding and delay or prolong delivery more than expected.
Do not take ibuprofen during the first 6 months of pregnancy unless it is absolutely necessary and your doctor tells you to. If you need treatment during this period or while trying to become pregnant, you should take the lowest dose for the shortest time possible. If you take it for more than a few daysafter week 20 of pregnancy, ibuprofen may cause kidney problems in your fetus, which may result in low amniotic fluid levels (oligohydramnios) or narrowing of a blood vessel (ductus arteriosus) in the baby's heart. If you need treatment for more than a few days, your doctor may recommend additional checks.
Although only small amounts of the medicationpass into breast milk, it is recommended not to takeibuprofen for prolonged periods during breastfeeding.
Therefore, if you become pregnant or are breastfeeding, consult your doctor.
Driving and operating machinery
If you experience dizziness, vertigo, visual disturbances, or other symptoms while taking this medication, do not drive or operate hazardous machinery. If you only take a single dose of ibuprofen or for a short period, no special precautions are necessary.
Ibuprofen may delay your reaction time, which should be taken into account before performing activities that require greater vigilance, such as driving and operating machinery.
This applies to a greater extent when combined with alcohol.
Ibuprofeno Almus contains lactose and sodium
This medication contains lactose. If your doctor has told you that you have a intolerance to certain sugars, consult with them before taking this medication.
This medication contains less than 1 mmolof sodium (23 mg) per tablet; it is essentially "sodium-free".
Your doctor will indicate the duration of treatment with ibuprofen. Do not discontinue treatment beforehand, as this will not yield the expected results. Similarly, do not use this medication for a longer period than indicated by your doctor.
The effective dose should be used for the shortest time necessary to alleviate symptoms. If you have an infection, consult a doctor without delay if symptoms (such as fever and pain) persist or worsen (see section 2).
Adults and adolescents over 14 years:
The recommended dose for adults and adolescents over 14 years is one tablet (600 mg) every 6 to 8 hours, depending on the severity of the condition and response to treatment.
In some cases, higher doses may be required, but in any case, it is recommended not to exceed the maximum daily dose of 2400 mg in adults and 1600 mg in adolescents aged 14 to 18 years.
Use in children and adolescents under 14 years:
This medication is not recommended for use in children or adolescents under 14 years, as the dose of ibuprofen contained is not suitable for the recommended dosage in these patients.
Older patients:
If you are over 60 years old, your doctor may prescribe a lower dose than usual. If this is the case, the dose can only be increased once your doctor has confirmed that you tolerate the medication well.
Patients with kidney and/or liver disease:
If you have kidney and/or liver disease, your doctor may prescribe a lower dose than usual. If this is the case, take the exact dose prescribed by your doctor.
Administration form
This medication is administered orally.
To achieve a faster onset of action, the dose can be taken on an empty stomach. Patients with sensitive stomachs are recommended to take ibuprofen with food.
Take ibuprofen with sufficient water. The tablets should be swallowed whole, with a glass of water, without chewing, breaking, crushing, or sucking to avoid mouth discomfort and throat irritation.
If you estimate that the action of this medication is too strong or too weak, inform your doctor or pharmacist.
If you take more doses of Ibuprofeno Almus than you should
If you have taken more Ibuprofeno Almus than you should, or if a child has accidentally ingested the medication, consult your doctor or pharmacist immediately, call the Toxicological Information Service, phone: 91 562 04 20, indicating the medication and the amount ingested, or go to the nearest hospital to inform yourself about the risk and ask for advice on the measures to be taken.
It is recommended to bring the packaging and the medication leaflet to the healthcare professional.
Normally, symptoms of overdose occur 4 to 6 hours after taking ibuprofen and may include: nausea, stomach pain, vomiting (which may contain blood-tinged mucus), headache, ringing in the ears, confusion, involuntary eye movement, and muscle coordination weakness. At high doses, symptoms of drowsiness, chest pain, palpitations, loss of consciousness, seizures (mainly in children), weakness, and dizziness, blood in the urine, low potassium levels in the blood, chills, and breathing difficulties have been reported. In rare cases, cases of metabolic acidosis, decreased body temperature, kidney function impairment, stomach and intestinal bleeding, coma, transient loss of breathing (apnea), central nervous system and respiratory system depression have been reported. Cases of cardiovascular toxicity (low blood pressure, decreased heart rate, and increased heart rate) have also been reported.
If a severe overdose has occurred, kidney failure and liver damage may occur. In these cases, the doctor will take the necessary measures.
In case of ingestion of significant amounts, activated charcoal should be administered.
If you forget to take Ibuprofeno Almus
Do not take a double dose to compensate for the missed doses.
If you forget to take your dose, take it as soon as you remember. However, if the next scheduled dose is soon, skip the missed dose and take the next dose at its usual time.
The side effects of medications such asIbuprofeno Almusare more common in people over 65 years old.
The incidence of side effects is lower in short-term treatments and if the daily dose is below the maximum recommended dose:
Exacerbation of inflammation related to infections has been observed coinciding with the use of NSAIDs. If signs of infection or these worsen during ibuprofen use, it is recommended to see a doctor as soon as possible.
A severe skin reaction known as DRESS syndrome (by its English acronym) may occur. The symptoms of DRESS syndrome include: skin rash, lymph node inflammation, and elevated eosinophils (a type of white blood cell).
Generalized red scaly rash, with bumps under the skin and localized blisters, mainly located in skin folds, trunk, and upper limbs, accompanied by fever at the beginning of treatment (generalized acute pustular exanthema). Stop taking Ibuprofeno Almus if you experience these symptoms and seek medical attention immediately (see section 2).
Interrupt the treatment with ibuprofen and seek medical attention immediately if you notice any of the following symptoms:
Reporting of side effects
If you experience any type of side effect, consult your doctor, pharmacist, or nurse, even if it is a possible side effect that does not appear in this prospectus. You can also report them directly through the Spanish System for the Pharmacovigilance of Medicinal Products for Human Use:https://www.notificaram.es.
By reporting side effects, you can contribute to providing more information on the safety of this medication.
Keepthis medication out of the sight and reach of children.
No special storage conditions are required.
Do not usethis medicationafter the expiration date that appears on the packaging after “CAD”. The expiration date is the last day of the month indicated.
Medicines should not be disposed of through drains or in the trash.Deposit the packaging and unused medications at the SIGRE collection pointat the pharmacy. If in doubt, ask your pharmacist how to dispose of unused packaging and medications.This will help protect the environment.
Composition of Ibuprofeno Almus
The active ingredient is ibuprofen.
The other components are: lactose monohydrate, cornstarch, hypromellose 6 CPS, anhydrous colloidal silica, microcrystalline cellulose, sodium croscarmellose, magnesium stearate, and opadry 04G 280001 white and purified water.
Appearance of the product and contents of the packaging
Ibuprofeno Almus are white, oval-shaped, coated tablets marked with a “237” on one face and smooth on the other face.
They are presented in packaging with 40 and 500 tablets.
Only some packaging sizes may be commercially available.
Holder of the marketing authorization and responsible for manufacturing
Holder of the marketing authorization:
Almus Farmacéutica, S.A.U.
Marie Curie, 54
08840 Viladecans, Barcelona,
Spain
Phone: 93 739 71 80
Email: [email protected]
Responsible for manufacturing:
Generis Farmacêutica, S.A
Rua João de Deus, No. 19
Venda Nova, Amadora
2700-487 Portugal
Date of the last review of this leaflet:November2024
The detailed information about this medicine is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es/
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.